Leukemia Clinical Trials in Los Angeles

Showing 701-720 of 1,205 trials

A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03484520

An open-label, dose-escalation study to assess safety, pharmacokinetics and efficacy as well as determine the recommended Phase 2 doses of co-administered therapy of dinaciclib and venetoclax for patients with relapsed or refractory Acute Myeloid Leukemia (R/R AML).

Cancer - Acute Myeloid Leukemia

AbbVie48 participantsStarted Jul 2018

Little Rock, Arkansas, United States • Los Angeles, California, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

NCT03090737

A study to evaluate the safety of Nivolumab in participants with advanced or metastatic non-small cell lung cancer

Non-Small Cell Lung Cancer

Bristol-Myers Squibb129 participantsStarted Jun 2017

Birmingham, Alabama, United States • Los Angeles, California, United States • Billings, Montana, United States +14 more locations

A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

Leukemia Trials in Other Cities

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Predictive Assay for Decision Making in Adjuvant Therapy

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

Other Conditions in Los Angeles